John Armitage - Egerton Capital – Largest Position Reductions (2025 Q3)
This report summarizes the most meaningful reductions and sell-offs made by John Armitage - Egerton Capital in 2025 Q3. The analysis highlights which positions were trimmed or exited, providing insight into how the investor adjusted risk exposure and portfolio strategy.
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| MSFT | 1,810,788 | $517.95 | Reduced | -1.80% | 9.89% | $937.9M | 2025 Q3 |
| PGR | 2,588,638 | $246.95 | Reduced | -1.87% | 6.74% | $639.26M | 2025 Q3 |
| CRH | 4,260,846 | $119.9 | Reduced | -6.78% | 5.39% | $510.88M | 2025 Q3 |
| COF | 2,077,839 | $212.58 | Reduced | -10.96% | 4.66% | $441.71M | 2025 Q3 |
| IBKR | 6,254,134 | $68.81 | Reduced | -22.37% | 4.54% | $430.35M | 2025 Q3 |
| META | 541,167 | $734.38 | Reduced | -1.84% | 4.19% | $397.42M | 2025 Q3 |
| STX | 1,592,983 | $236.06 | Reduced | -22.35% | 3.97% | $376.04M | 2025 Q3 |
| FLUT | 1,412,018 | $254 | Reduced | -2.61% | 3.78% | $358.65M | 2025 Q3 |
| CRS | 1,374,333 | $245.54 | Reduced | -28.01% | 3.56% | $337.45M | 2025 Q3 |
| CME | 1,184,788 | $270.19 | Reduced | -22.20% | 3.38% | $320.12M | 2025 Q3 |
| ACGL | 3,507,882 | $90.73 | Reduced | -17.29% | 3.36% | $318.27M | 2025 Q3 |
| ICE | 1,036,199 | $168.48 | Reduced | -4.05% | 1.84% | $174.58M | 2025 Q3 |
| CP | 2,026,311 | $74.49 | Reduced | -55.54% | 1.59% | $150.94M | 2025 Q3 |
| FCNCA | 47,384 | $1789.17 | Reduced | -46.77% | 0.89% | $84.78M | 2025 Q3 |
共 1 页